Chemical inhibitors of AU021838 can exert their inhibitory effects through various mechanisms, targeting different pathways and processes that are crucial for the protein's function. Staurosporine is a potent inhibitor that directly targets the kinase activity of AU021838. It blocks the ATP binding site within the kinase domain of AU021838, which is essential for its phosphorylation activity. This inhibition prevents AU021838 from catalyzing the transfer of phosphate groups to its substrates, thus impeding its role in signaling cascades. Similarly, Imatinib operates by inhibiting certain tyrosine kinases, which can lead to the downstream inhibition of AU021838 if it is a component of tyrosine kinase-dependent signaling pathways. This inhibition could prevent AU021838 from participating in cellular processes that rely on phosphorylation events mediated by tyrosine kinases.
Moreover, several inhibitors target upstream components of pathways involving AU021838, which results in the subsequent inhibition of the protein. LY294002 and Wortmannin, for instance, both inhibit phosphoinositide 3-kinases (PI3K). Since PI3K is an upstream regulator in many signaling pathways, the inhibition by these chemicals can lead to a decrease in AU021838 activity if it operates within the PI3K/Akt pathway. U0126 and PD98059 target MEK1, and by inhibiting MEK, they can decrease the activity of the extracellular signal-regulated kinase (ERK) pathway. If AU021838 is downstream of this pathway, its activity would be reduced as a result. SB203580 and SP600125 inhibit p38 MAP kinase and c-Jun N-terminal kinase (JNK), respectively. The inhibition of these kinases can reduce the activity of AU021838 if it is a downstream effector in these MAPK pathways. Lastly, Bisindolylmaleimide I specifically inhibits protein kinase C (PKC), which can lead to the inhibition of AU021838 if it is involved in PKC-dependent signaling pathways, highlighting a method by which the function of AU021838 can be inhibited through interference with its regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits the kinase activity of AU021838 by preventing ATP from binding to the kinase domain, thereby blocking phosphorylation processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway, reducing the activity of downstream proteins including AU021838 if it is involved in mTOR signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which is upstream of many proteins including AU021838, leading to inhibition of AU021838's activity if it is in the PI3K pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, which could decrease ERK pathway activity, leading to functional inhibition of AU021838 if it is a part of this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1 and thereby inhibits the ERK pathway, which could result in the inhibition of AU021838 if it is associated with this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K and could inhibit downstream proteins like AU021838 if they are part of the PI3K/Akt pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially inhibiting AU021838 activity if it is a downstream target of the p38 MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which could lead to inhibition of AU021838 if it operates downstream of the JNK signaling pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Inhibits Src family kinases, potentially inhibiting AU021838 if it is involved in signaling pathways that include Src kinases. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits certain tyrosine kinases, which could lead to functional inhibition of AU021838 if it is part of tyrosine kinase signaling pathways. | ||||||